Literature DB >> 9305186

Intentional limited resection for selected patients with T1 N0 M0 non-small-cell lung cancer: a single-institution study.

K Kodama1, O Doi, M Higashiyama, H Yokouchi.   

Abstract

OBJECTIVES: To comparatively evaluate lobectomy and limited resection for T1 N0 M0 non-small-cell lung cancer, we reviewed case series with concurrent nonrandomized controls.
METHODS: Limited resection with curative intent was performed for 63 patients with T1 N0 M0 non-small-cell lung cancer over a 10-year period. These 63 patients included 46 patients who underwent a segmentectomy as an intentional limited resection. These patients had good pulmonary function and could tolerate a lobectomy in the management of their disease. The other 17 patients underwent wedge resection or segmentectomy as a compromised limited resection because they had poor pulmonary reserve or other limiting factors and could withstand a thoracotomy but could not tolerate a lobectomy in the management of their disease.
RESULTS: The 5-year survival was 93% in the intentional resection group. The survival curve for this group was not different from that for 77 patients who underwent the standard operation (lobectomy plus complete mediastinal lymph node dissection) for T1 N0 M0 non-small-cell lung cancer during the same period. The frequency of local/regional recurrence in the intentional resection group was 8.7% (4/46); the recurrence in three patients was situated in the mediastinum. According to multivariate analysis, limited resection was not associated with poor survival.
CONCLUSION: Segmentectomy with regional lymph node dissection, including the mediastinum, should be considered as an acceptable alternative treatment for selected patients with T1 N0 M0 disease.

Entities:  

Mesh:

Year:  1997        PMID: 9305186     DOI: 10.1016/S0022-5223(97)70179-X

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  58 in total

1.  Radiologic and nuclear medicine predictors of tumor invasiveness in patients with clinical stage IA lung adenocarcinoma.

Authors:  Masaya Tamura; Makoto Oda; Isao Matsumoto; Yosuke Shimizu; Ryuichi Waseda; Go Watanabe
Journal:  World J Surg       Date:  2011-09       Impact factor: 3.352

2.  Clinical implications of the margin cytology findings and margin/tumor size ratio in patients who underwent pulmonary excision for peripheral non-small cell lung cancer.

Authors:  Noriyoshi Sawabata; Hajime Maeda; Akihide Matsumura; Mitsunori Ohta; Meinoshin Okumura
Journal:  Surg Today       Date:  2011-11-10       Impact factor: 2.549

Review 3.  Lung cancer. 6: The case for limited surgical resection in non-small cell lung cancer.

Authors:  D J Sugarbaker
Journal:  Thorax       Date:  2003-07       Impact factor: 9.139

4.  cT1aN0M0 lung adenocarcinoma treated with left S9+10 segmentectomy followed by completion lobectomy for a solitary metastasis (isolated tumor cells) in the neighboring segmental lymph node.

Authors:  Kohei Hashimoto; Takashi Ohtsuka; Mitsutomo Kohno; Yotaro Izumi; Hirohisa Horinouchi; Yuichiro Hayashi; Tadaki Nakahara; Hiroaki Nomori
Journal:  Gen Thorac Cardiovasc Surg       Date:  2012-03-28

5.  A segmentectomy of the right upper lobe has an advantage over a right upper lobectomy regarding the preservation of the functional volume of the right middle lobe: analysis by perfusion single-photon emission computed tomography/computed tomography.

Authors:  Kentaro Yoshimoto; Hiroaki Nomori; Takeshi Mori; Yasuomi Ohba; Hidekatsu Shibata; Kuniyuki Tashiro; Shinya Shiraishi; Toshiaki Kobayashi
Journal:  Surg Today       Date:  2010-06-26       Impact factor: 2.549

Review 6.  Early-stage lung cancer: diagnosis and treatment.

Authors:  Tatsuo Ohira; Yasuhiro Suga; Yoshitaka Nagatsuka; Jitsuo Usuda; Masahiro Tsuboi; Takashi Hirano; Norihiko Ikeda; Harubumi Kato
Journal:  Int J Clin Oncol       Date:  2006-02       Impact factor: 3.402

Review 7.  Radical sublobar resection for lung cancer.

Authors:  Morihito Okada
Journal:  Gen Thorac Cardiovasc Surg       Date:  2008-04-10

8.  Segmentectomy versus lobectomy for stage I non-small cell lung cancer: a systematic review and meta-analysis.

Authors:  Benedetta Bedetti; Luca Bertolaccini; Raffaele Rocco; Joachim Schmidt; Piergiorgio Solli; Marco Scarci
Journal:  J Thorac Dis       Date:  2017-06       Impact factor: 2.895

9.  Limited resection versus lobectomy in early-stage non-small cell lung cancer.

Authors:  Paul A Toste; Jay M Lee
Journal:  J Thorac Dis       Date:  2016-11       Impact factor: 2.895

10.  Outcomes: wedge resection versus lobectomy for non-small cell lung cancer at the Cancer Centre of Southeastern Ontario 1998-2009.

Authors:  Anna L McGuire; Wilma M Hopman; Dimitri Petsikas; Ken Reid
Journal:  Can J Surg       Date:  2013-12       Impact factor: 2.089

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.